Anesthetic management of a patient with multiple sclerosis – case report  by Zuccolotto, Eduardo Barbin et al.
RC
A
s
E
R
J
C
R
R
A
h
0
Bev Bras Anestesiol. 2016;66(4):414--417
REVISTA
BRASILEIRA  DE
ANESTESIOLOGIA Publicação  Oﬁcial  da  Sociedade  Brasileira  de  Anestesiologiawww.sba.com.br
LINICAL INFORMATION
nesthetic  management  of  a patient  with multiple
clerosis --  case  report
duardo Barbin Zuccolotto, Guilherme Coelho Machado Nunes,
afael  Soares Lopes Nogueira, Eugenio Pagnussatt Neto ∗,
osé  Roberto Nociti
entro  de  Ensino  e  Treinamento  em  Anestesiologia  (CET-SBA),  Clinica  de  Anestesiologia  de  Ribeirão  Preto  (CARP),
ibeirão Preto,  SP,  Brazil
eceived  20  February  2014;  accepted  19  March  2014
vailable  online  25  April  2016
KEYWORDS
Multiple  sclerosis;
Urologic  surgery;
Propofol;
Sevoﬂurane;
Remifentanil
Abstract
Background  and  objectives:  Multiple  sclerosis  is  a  demyelinating  disease  of  the  brain  and  spinal
cord, characterized  by  muscle  weakness,  cognitive  dysfunction,  memory  loss,  and  personality
disorders.  Factors  that  promote  disease  exacerbation  are  stress,  physical  trauma,  infection,
surgery,  and  hyperthermia.  The  objective  is  to  describe  the  anesthetic  management  of  a  case
referred  to  urological  surgery.
Case  report:  A  female  patient,  44  years  of  age,  with  multiple  sclerosis,  diagnosed  with
nephrolithiasis,  referred  for  endoscopic  ureterolythotripsy.  Balanced  general  anesthesia  was
chosen, with  midazolam,  propofol  and  remifentanil  target-controlled  infusion;  sevoﬂurane
via laryngeal  mask  airway;  and  spontaneous  ventilation.  Because  the  patient  had  respira-
tory difﬁculty  presenting  with  chest  wall  rigidity,  it  was  decided  to  discontinue  the  infusion
of remifentanil.  There  was  no  other  complication  or  exacerbation  of  disease  postoperatively.
Conclusion:  The  use  of  neuromuscular  blockers  (depolarizing  and  non-depolarizing)  is  a  problem
in these  patients.  As  there  was  no  need  for  muscle  relaxation  in  this  case,  muscle  relaxants
were omitted.  We  conclude  that  the  combination  of  propofol  and  sevoﬂurane  was  satisfactory,
not resulting  in  hemodynamic  instability  or  disease  exacerbation.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).∗ Corresponding author.
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ttp://dx.doi.org/10.1016/j.bjane.2014.03.013
104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
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Controle  anestésico  de  paciente  com  esclerose  múltipla  --  relato  de  caso
Resumo
Justiﬁcativa  e  objetivos:  Esclerose  múltipla  é  doenc¸a  desmielinizante  do  cérebro  e  da  medula
espinhal, caracterizada  por  fraqueza  muscular,  disfunc¸ão  cognitiva,  perda  da  memória,
alterac¸ões de  personalidade.  Fatores  que  promovem  exacerbac¸ão  da  doenc¸a  são  estresse,
trauma físico,  infecc¸ões,  cirurgias,  hipertermia.  O  objetivo  é  descrever  a  abordagem  anestésica
de um  caso  encaminhado  a  cirurgia  urológica.
Relato  de  caso: Paciente  do  sexo  feminino,  44  anos,  portadora  de  esclerose  múltipla,  com
o diagnóstico  de  nefrolitíase,  é  encaminhada  a  ureterolitotripsia  endoscópica.  Optou-se
por anestesia  geral  balanceada  com  midazolam,  propofol  e  remifentanil  em  infusão  alvo-
controlada,  sevoﬂurano  sob  máscara  laríngea  e  ventilac¸ão  espontânea.  Tendo  apresentado
diﬁculdade  ventilatória  por  tórax  rígido,  optou-se  por  interromper  a  infusão  de  remifentanil.
Não se  registraram  outras  intercorrências  nem  exacerbac¸ão  da  doenc¸a  no  pós-operatório.
Conclusão:  O  uso  de  bloqueadores  neuromusculares  (tanto  despolarizantes  como  não-
despolarizantes)  constitui  um  problema  nestes  pacientes.  Como  não  havia  necessidade  de
relaxamento  muscular  neste  caso,  eles  foram  omitidos.  Concluímos  que  a  associac¸ão  de  propofol
e sevoﬂurano  foi  satisfatória,  não  resultando  em  instabilidade  hemodinâmica  nem  exacerbac¸ão
da doenc¸a.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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iIntroduction
Multiple  sclerosis  (MS)  is  a  demyelinating  disease  of
the  brain  and  spinal  cord  (peripheral  nerves  are  not
affected),  with  remissions  and  chronic  relapses  or  pro-
gressive  course.  It  is  possibly  caused  by  the  interaction
between  genetic  and  environmental  factors,  whose  exact
etiology  is  unknown.  It  is  characterized  by  loss  of  muscle
strength,  initially  reversible;  cognitive  dysfunction;  mem-
ory  loss;  personality  changes;  and  emotional  lability.1--5
Symptoms  appear  between  the  ages  of  20  and  40,  with
prevalence  8  times  higher  in  females4;  nevertheless,  in
the  case  of  male  patients,  the  exacerbation  is  potentially
more  serious,  with  lower  survival  rate.6 Associated  con-
ditions  include  convulsions  and  uveitis.  Muscle  breakdown
causes  hyperkalemia  and  the  possibility  of  neuromuscular
blocking  agent  overdose.  Chronic  treatment  with  corti-
costeroids  predisposes  to  adrenal  suppression  and  gastric
ulceration.4
The  clinically  established  factors  for  disease  exacerba-
tion  include  stress  crises  and  physical  trauma,  infections,
surgery,  hyperthermia,  puerperal  period.2,5,7 Study  aimed
at  verifying  whether  occupational  exposure  to  inhaled  anes-
thetic  agents  could  increase  the  risk  of  MS  occurrence  in
professionals  found  no  relationship  between  this  factor  and
the  development  of  disease.8
The  treatment  has  been  directed  to  controlling  the  signs
and  symptoms  and  disease  progression.  Corticosteroids  are
the  treatment  base,  thanks  to  its  immunomodulatory  and
anti-inﬂammatory  action.  Interferon  beta  is  the  agent  of
choice  for  patients  with  relapsing-remitting,  or  glatiramer
acetate  as  an  alternative.  The  immunosuppressant  azathio-
prine  is  effective  in  reducing  the  frequency  of  relapses,  but
not  during  a  disease  remission.5
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Sase report
emale  patient,  44  years  old,  with  severe  colic  abdomi-
al  pain  in  the  right  ﬂank  with  irradiation  to  the  ventral
egion.  Evaluated  by  the  urology  team,  the  patient  was
iagnosed  with  nephrolithiasis  and  indicated  for  endoscopic
reterolythotripsy.  The  patient  reported  having  MS,  whose
ymptoms  had  began  ten  years  ago  associated  with  loss
f  balance;  paresthesia  in  the  right  leg;  diplopia;  and
abial  commissure  deviation.  About  two  years  ago,  with  the
iagnosis  established,  she  began  to  be  followed  by  a  neurol-
gist.  At  that  time,  she  was  taking  natalizumab,  gabapentin
00  mg  day−1, and  baclofen  10  mg  twice  daily.  The  last  cri-
is  happened  more  than  a  year  ago.  The  patient  denied
ther  comorbidities,  regular  use  of  other  medications,  and
istory  of  allergies.  She  was  submitted  to  three  previous
esarean  sections  25,  22  and  19  years  ago,  and  received
pinal  anesthesia  in  the  ﬁrst  two  and  epidural  block  in  the
hird  procedure.  Currently,  she  cannot  walk  due  to  severe
uscle  weakness  in  both  legs.
The  patient  was  admitted  to  the  operating  room  in  a
heelchair,  lucid  and  oriented,  with  hemodynamic  stability,
pontaneous  ventilation  and  adequate  period  of  preoper-
tive  fasting.  After  peripheral  vein  catheterization  in  the
ight  upper  limb  and  routine  monitoring  (pulse  oximetry,
ardioscopy,  noninvasive  blood  pressure,  capnometry),  gen-
ral  anesthesia  was  induced  using  the  balanced  technique:
idazolam  0.02  mg  kg−1, followed  by  remifentanil  in  target-
ontrolled  infusion  (3  ng  mL−1),  propofol  in  target-controlled
nfusion  (3  ng  mL−1),  and  sevoﬂurane  1.0  MAC  under  laryn-
eal  mask.  The  patient  presented  with  respiratory  difﬁculty,
y  chest-wall  rigidity,  readily  treated  by  mechanical  venti-
ation,  opting  for  interrupting  the  infusion  of  remifentanil.
he  underwent  surgery  in  the  lithotomy  position,  and  the
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116  
rocedure  lasted  60  min.  There  were  no  complications  intra-
peratively,  and  at  the  end  of  surgery,  she  was  taken  to
he  post-anesthetic  care  unit,  awaken  and  with  stable  and
symptomatic  vital  conditions.  There  was  no  exacerbation
f  MS  postoperatively.
iscussion
nesthetic  and  perioperative  stress  are  factors  that  can  trig-
er  exacerbation  crisis  of  MS;  therefore,  individuals  with
S  subjected  to  a  surgical-anesthetic  procedure  are  at
ncreased  risk  of  neurological  dysfunction  compared  with
ndividuals  without  MS.1
Case  reports  and  retrospective  studies  are  limited  in
etermining  the  effects  of  anesthetic  techniques  and  peri-
perative  management  of  patients  with  MS.  The  available
ata  do  not  support  the  hypothesis  that  anesthesia  may  be
ssociated  with  new  demyelinating  lesions  in  patients  with
S.2
Neuraxial  blockade  in  patients  with  MS  is  controver-
ial  due  to  the  potential  neurotoxicity  of  local  anesthetics,
articularly  in  demyelinated  nerves.2,4 However,  several
etrospective  studies  do  not  report  signiﬁcant  increase  in
xacerbations  when  local  anesthetics  are  administered  in
he  epidural  or  subarachnoid  space.2,6,9 But,  in  case  of  a
recise  indication  for  performing  neuraxial  blockade,  some
uthors  have  the  opinion  that  the  epidural  technique  should
e  preferred.4,10
Perioperative  hyperthermia  may  be  a  cause  of  recurrence
nd  postoperative  exacerbation  of  MS  because  it  alters  nerve
onduction  in  demyelinated  regions.4,6 In  our  case,  we  per-
orm  volume  replacement  with  cold  solutions,  as  well  as
ooling  the  patient.
Intravenous  induction  agents  or  inhalation  anesthetics  do
ot  appear  to  have  adverse  effects  on  nerve  conduction  and
he  available  literature  does  not  associate  them  with  pro-
ression  of  MS.2 In  most  case  reports,  sevoﬂurane  was  used
or  anesthetic  maintenance  without  reference  to  postopera-
ive  exacerbations  of  the  disease.11,12
The  use  of  neuromuscular  blockers  is  a  problem:  suc-
inylcholine  should  be  avoided  due  the  occurrence  of
yperkalemia;  non-depolarizing  agents  should  be  avoided,
specially  in  cases  of  large  muscular  destruction,  and
hen  necessary,  it  should  be  used  under  strict  monitoring.6
ecause  the  procedure  did  not  require  muscle  relax-
tion,  and  airway  management  occurred  without  tracheal
ntubation,  we  did  not  use  neuromuscular  blockers.  Pharma-
ologic  treatment  of  spasticity  includes  the  use  of  baclofen
nd  tizanidine  systemically,  botulinum  toxin,  alcohol,  and
henol  locally,  with  the  ﬁrst  two  considered  ﬁrst-line
reatment.8,13 The  use  of  baclofen  to  control  muscle  spasms,
s  was  the  case  with  this  patient,  is  appropriate  although  it
an  decrease  muscle  mass.6 Venous  thrombosis  is  a  risk  fac-
or  in  patients  with  exacerbated  MS  after  spinal  puncture  or
sing  high  doses  of  corticosteroids,  and  prophylactic  treat-
ent  is  indicated.10 It  was  not  the  case  with  our  patient.
he  disease  has  periods  of  exacerbation  and  remissions  at
npredictable  intervals,  and  when  only  pregnant  women
re  considered,  more  than  half  of  relapses  occur  in  the
ostpartum  period,  usually  within  the  ﬁrst  3  months.9,14
his  risk  is  not  related  to  the  type  of  anesthetic  tech-
ique  or  parity.14 Some  case  reports  have  shown  good
1E.B.  Zuccolotto  et  al.
esults  with  subarachnoid  block  for  cesarean  section  with
o  signs  of  MS  exacerbation,  even  in  patients  followed  for
p  to  12  months  after  the  procedure.9,15,16 Others  attest
hat  the  well  performed  epidural  block  is  associated  with
inimal  risk  of  postpartum  exacerbation.10,17 There  is  no
onsensus  on  the  best  technique  for  pregnant  women  with
S.
Despite  the  low  level  of  evidence,  there  are  some  studies
hat  support  the  preoperative  use  of  anxiolytic  to  control
motional  disturbances  that  can  trigger  exacerbations,  as
ell  as  the  adequate  control  of  postoperative  pain.6
onclusion
egional  or  neuraxial  anesthesia  does  not  have  absolute  con-
raindication  for  patients  with  MS,  but  lower  concentrations
f  local  anesthetics  and  care  in  handling  them  are  par-
icularly  important.  These  patients  have  a  higher  risk  for
utonomic  dysfunction,  and  they  should  be  strictly  followed.
hose  with  the  disease  at  a  more  advanced  stage  are  at
ncreased  risk  for  perioperative  depression,  hypoventilation,
telectasis,  and  sleep  apnea.  The  use  of  depolarizing  neu-
omuscular  blockers  should  be  avoided  and  non-depolarizing
gents  should  be  used  under  monitoring.
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